Injection bioavailability is more consistent, potentially accelerating dose escalation timelines
Some absorption enhancers, particularly surfactant-based compounds, achieve their effects by partially disrupting the mucosal barrier
Most patients begin noticing appetite changes during this phase
Insurance battles can be frustrating, and many doctors remain hesitant about prescribing expensive weight loss drugs
Based on the STEP-1 clinical trial, the average weight loss with semaglutide 2.4 mg weekly is 14.9% of body weight over 68 weeks (about 16 months)
GIP receptors are found throughout the body, and their activation improves how cells respond to insulin (insulin sensitivity) and appears to promote more favorable fat distribution (less visceral fat around organs, more subcutaneous fat under the skin)